Global Castration Resistant Prostate Cancer Treatment Market Insights and Forecast to 2031

Report ID: 1665305 | Published Date: Jan 2025 | No. of Page: 87 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Castration Resistant Prostate Cancer Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Hormonal Therapy
        1.2.3 Adding An Anti-Androgen
        1.2.4 Stopping An Anti-Androgen
        1.2.5 Estrogens
        1.2.6 Chemotherapy
        1.2.7 Radiation Therapy
        1.2.8 Others
    1.3 Market by Application
        1.3.1 Global Castration Resistant Prostate Cancer Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Ambulatory Surgical Centers
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Castration Resistant Prostate Cancer Treatment Market Perspective (2017-2028)
    2.2 Castration Resistant Prostate Cancer Treatment Growth Trends by Region
        2.2.1 Castration Resistant Prostate Cancer Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Castration Resistant Prostate Cancer Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Castration Resistant Prostate Cancer Treatment Market Dynamics
        2.3.1 Castration Resistant Prostate Cancer Treatment Industry Trends
        2.3.2 Castration Resistant Prostate Cancer Treatment Market Drivers
        2.3.3 Castration Resistant Prostate Cancer Treatment Market Challenges
        2.3.4 Castration Resistant Prostate Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Castration Resistant Prostate Cancer Treatment Players by Revenue
        3.1.1 Global Top Castration Resistant Prostate Cancer Treatment Players by Revenue (2017-2022)
        3.1.2 Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Castration Resistant Prostate Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Castration Resistant Prostate Cancer Treatment Revenue
    3.4 Global Castration Resistant Prostate Cancer Treatment Market Concentration Ratio
        3.4.1 Global Castration Resistant Prostate Cancer Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Castration Resistant Prostate Cancer Treatment Revenue in 2021
    3.5 Castration Resistant Prostate Cancer Treatment Key Players Head office and Area Served
    3.6 Key Players Castration Resistant Prostate Cancer Treatment Product Solution and Service
    3.7 Date of Enter into Castration Resistant Prostate Cancer Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Castration Resistant Prostate Cancer Treatment Breakdown Data by Type
    4.1 Global Castration Resistant Prostate Cancer Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Type (2023-2028)
5 Castration Resistant Prostate Cancer Treatment Breakdown Data by Application
    5.1 Global Castration Resistant Prostate Cancer Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Castration Resistant Prostate Cancer Treatment Market Size (2017-2028)
    6.2 North America Castration Resistant Prostate Cancer Treatment Market Size by Type
        6.2.1 North America Castration Resistant Prostate Cancer Treatment Market Size by Type (2017-2022)
        6.2.2 North America Castration Resistant Prostate Cancer Treatment Market Size by Type (2023-2028)
        6.2.3 North America Castration Resistant Prostate Cancer Treatment Market Share by Type (2017-2028)
    6.3 North America Castration Resistant Prostate Cancer Treatment Market Size by Application
        6.3.1 North America Castration Resistant Prostate Cancer Treatment Market Size by Application (2017-2022)
        6.3.2 North America Castration Resistant Prostate Cancer Treatment Market Size by Application (2023-2028)
        6.3.3 North America Castration Resistant Prostate Cancer Treatment Market Share by Application (2017-2028)
    6.4 North America Castration Resistant Prostate Cancer Treatment Market Size by Country
        6.4.1 North America Castration Resistant Prostate Cancer Treatment Market Size by Country (2017-2022)
        6.4.2 North America Castration Resistant Prostate Cancer Treatment Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Castration Resistant Prostate Cancer Treatment Market Size (2017-2028)
    7.2 Europe Castration Resistant Prostate Cancer Treatment Market Size by Type
        7.2.1 Europe Castration Resistant Prostate Cancer Treatment Market Size by Type (2017-2022)
        7.2.2 Europe Castration Resistant Prostate Cancer Treatment Market Size by Type (2023-2028)
        7.2.3 Europe Castration Resistant Prostate Cancer Treatment Market Share by Type (2017-2028)
    7.3 Europe Castration Resistant Prostate Cancer Treatment Market Size by Application
        7.3.1 Europe Castration Resistant Prostate Cancer Treatment Market Size by Application (2017-2022)
        7.3.2 Europe Castration Resistant Prostate Cancer Treatment Market Size by Application (2023-2028)
        7.3.3 Europe Castration Resistant Prostate Cancer Treatment Market Share by Application (2017-2028)
    7.4 Europe Castration Resistant Prostate Cancer Treatment Market Size by Country
        7.4.1 Europe Castration Resistant Prostate Cancer Treatment Market Size by Country (2017-2022)
        7.4.2 Europe Castration Resistant Prostate Cancer Treatment Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Type
        8.2.1 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Share by Type (2017-2028)
    8.3 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Application
        8.3.1 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Share by Application (2017-2028)
    8.4 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Region
        8.4.1 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Castration Resistant Prostate Cancer Treatment Market Size (2017-2028)
    9.2 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Type
        9.2.1 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Type (2017-2022)
        9.2.2 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Type (2023-2028)
        9.2.3 Latin America Castration Resistant Prostate Cancer Treatment Market Share by Type (2017-2028)
    9.3 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Application
        9.3.1 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Application (2017-2022)
        9.3.2 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Application (2023-2028)
        9.3.3 Latin America Castration Resistant Prostate Cancer Treatment Market Share by Application (2017-2028)
    9.4 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Country
        9.4.1 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Country (2017-2022)
        9.4.2 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Type
        10.2.1 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Share by Type (2017-2028)
    10.3 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Application
        10.3.1 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Share by Application (2017-2028)
    10.4 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Country
        10.4.1 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Active Biotech
        11.1.1 Active Biotech Company Details
        11.1.2 Active Biotech Business Overview
        11.1.3 Active Biotech Castration Resistant Prostate Cancer Treatment Introduction
        11.1.4 Active Biotech Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
        11.1.5 Active Biotech Recent Developments
    11.2 Diagnocure
        11.2.1 Diagnocure Company Details
        11.2.2 Diagnocure Business Overview
        11.2.3 Diagnocure Castration Resistant Prostate Cancer Treatment Introduction
        11.2.4 Diagnocure Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
        11.2.5 Diagnocure Recent Developments
    11.3 Glaxosmithkline
        11.3.1 Glaxosmithkline Company Details
        11.3.2 Glaxosmithkline Business Overview
        11.3.3 Glaxosmithkline Castration Resistant Prostate Cancer Treatment Introduction
        11.3.4 Glaxosmithkline Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
        11.3.5 Glaxosmithkline Recent Developments
    11.4 Northwest Biotherapeutics
        11.4.1 Northwest Biotherapeutics Company Details
        11.4.2 Northwest Biotherapeutics Business Overview
        11.4.3 Northwest Biotherapeutics Castration Resistant Prostate Cancer Treatment Introduction
        11.4.4 Northwest Biotherapeutics Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
        11.4.5 Northwest Biotherapeutics Recent Developments
    11.5 Millennium Pharmaceuticals
        11.5.1 Millennium Pharmaceuticals Company Details
        11.5.2 Millennium Pharmaceuticals Business Overview
        11.5.3 Millennium Pharmaceuticals Castration Resistant Prostate Cancer Treatment Introduction
        11.5.4 Millennium Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
        11.5.5 Millennium Pharmaceuticals Recent Developments
    11.6 Hologic
        11.6.1 Hologic Company Details
        11.6.2 Hologic Business Overview
        11.6.3 Hologic Castration Resistant Prostate Cancer Treatment Introduction
        11.6.4 Hologic Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
        11.6.5 Hologic Recent Developments
    11.7 Spectrum Pharmaceuticals
        11.7.1 Spectrum Pharmaceuticals Company Details
        11.7.2 Spectrum Pharmaceuticals Business Overview
        11.7.3 Spectrum Pharmaceuticals Castration Resistant Prostate Cancer Treatment Introduction
        11.7.4 Spectrum Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
        11.7.5 Spectrum Pharmaceuticals Recent Developments
    11.8 Abbott Laboratories
        11.8.1 Abbott Laboratories Company Details
        11.8.2 Abbott Laboratories Business Overview
        11.8.3 Abbott Laboratories Castration Resistant Prostate Cancer Treatment Introduction
        11.8.4 Abbott Laboratories Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
        11.8.5 Abbott Laboratories Recent Developments
    11.9 Bayer Healthcare Pharmaceuticals
        11.9.1 Bayer Healthcare Pharmaceuticals Company Details
        11.9.2 Bayer Healthcare Pharmaceuticals Business Overview
        11.9.3 Bayer Healthcare Pharmaceuticals Castration Resistant Prostate Cancer Treatment Introduction
        11.9.4 Bayer Healthcare Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
        11.9.5 Bayer Healthcare Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Castration Resistant Prostate Cancer Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Hormonal Therapy
    Table 3. Key Players of Adding An Anti-Androgen
    Table 4. Key Players of Stopping An Anti-Androgen
    Table 5. Key Players of Estrogens
    Table 6. Key Players of Chemotherapy
    Table 7. Key Players of Radiation Therapy
    Table 8. Key Players of Others
    Table 9. Global Castration Resistant Prostate Cancer Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 10. Global Castration Resistant Prostate Cancer Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 11. Global Castration Resistant Prostate Cancer Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 12. Global Castration Resistant Prostate Cancer Treatment Market Share by Region (2017-2022)
    Table 13. Global Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 14. Global Castration Resistant Prostate Cancer Treatment Market Share by Region (2023-2028)
    Table 15. Castration Resistant Prostate Cancer Treatment Market Trends
    Table 16. Castration Resistant Prostate Cancer Treatment Market Drivers
    Table 17. Castration Resistant Prostate Cancer Treatment Market Challenges
    Table 18. Castration Resistant Prostate Cancer Treatment Market Restraints
    Table 19. Global Castration Resistant Prostate Cancer Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 20. Global Castration Resistant Prostate Cancer Treatment Revenue Share by Players (2017-2022)
    Table 21. Global Top Castration Resistant Prostate Cancer Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Castration Resistant Prostate Cancer Treatment as of 2021)
    Table 22. Ranking of Global Top Castration Resistant Prostate Cancer Treatment Companies by Revenue (US$ Million) in 2021
    Table 23. Global 5 Largest Players Market Share by Castration Resistant Prostate Cancer Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players Castration Resistant Prostate Cancer Treatment Product Solution and Service
    Table 26. Date of Enter into Castration Resistant Prostate Cancer Treatment Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Castration Resistant Prostate Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 29. Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Type (2017-2022)
    Table 30. Global Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 31. Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Type (2023-2028)
    Table 32. Global Castration Resistant Prostate Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 33. Global Castration Resistant Prostate Cancer Treatment Revenue Share by Application (2017-2022)
    Table 34. Global Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 35. Global Castration Resistant Prostate Cancer Treatment Revenue Share by Application (2023-2028)
    Table 36. North America Castration Resistant Prostate Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 37. North America Castration Resistant Prostate Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 38. North America Castration Resistant Prostate Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 39. North America Castration Resistant Prostate Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 40. North America Castration Resistant Prostate Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 41. North America Castration Resistant Prostate Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Europe Castration Resistant Prostate Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 43. Europe Castration Resistant Prostate Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 44. Europe Castration Resistant Prostate Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 45. Europe Castration Resistant Prostate Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 46. Europe Castration Resistant Prostate Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 47. Europe Castration Resistant Prostate Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Castration Resistant Prostate Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Castration Resistant Prostate Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 50. Asia Pacific Castration Resistant Prostate Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 51. Asia Pacific Castration Resistant Prostate Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 52. Asia Pacific Castration Resistant Prostate Cancer Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 53. Asia Pacific Castration Resistant Prostate Cancer Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 54. Latin America Castration Resistant Prostate Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 55. Latin America Castration Resistant Prostate Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 56. Latin America Castration Resistant Prostate Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 57. Latin America Castration Resistant Prostate Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 58. Latin America Castration Resistant Prostate Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 59. Latin America Castration Resistant Prostate Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Castration Resistant Prostate Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Castration Resistant Prostate Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa Castration Resistant Prostate Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa Castration Resistant Prostate Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 64. Middle East and Africa Castration Resistant Prostate Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 65. Middle East and Africa Castration Resistant Prostate Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 66. Active Biotech Company Details
    Table 67. Active Biotech Business Overview
    Table 68. Active Biotech Castration Resistant Prostate Cancer Treatment Product
    Table 69. Active Biotech Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 70. Active Biotech Recent Developments
    Table 71. Diagnocure Company Details
    Table 72. Diagnocure Business Overview
    Table 73. Diagnocure Castration Resistant Prostate Cancer Treatment Product
    Table 74. Diagnocure Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 75. Diagnocure Recent Developments
    Table 76. Glaxosmithkline Company Details
    Table 77. Glaxosmithkline Business Overview
    Table 78. Glaxosmithkline Castration Resistant Prostate Cancer Treatment Product
    Table 79. Glaxosmithkline Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 80. Glaxosmithkline Recent Developments
    Table 81. Northwest Biotherapeutics Company Details
    Table 82. Northwest Biotherapeutics Business Overview
    Table 83. Northwest Biotherapeutics Castration Resistant Prostate Cancer Treatment Product
    Table 84. Northwest Biotherapeutics Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 85. Northwest Biotherapeutics Recent Developments
    Table 86. Millennium Pharmaceuticals Company Details
    Table 87. Millennium Pharmaceuticals Business Overview
    Table 88. Millennium Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product
    Table 89. Millennium Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 90. Millennium Pharmaceuticals Recent Developments
    Table 91. Hologic Company Details
    Table 92. Hologic Business Overview
    Table 93. Hologic Castration Resistant Prostate Cancer Treatment Product
    Table 94. Hologic Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 95. Hologic Recent Developments
    Table 96. Spectrum Pharmaceuticals Company Details
    Table 97. Spectrum Pharmaceuticals Business Overview
    Table 98. Spectrum Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product
    Table 99. Spectrum Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 100. Spectrum Pharmaceuticals Recent Developments
    Table 101. Abbott Laboratories Company Details
    Table 102. Abbott Laboratories Business Overview
    Table 103. Abbott Laboratories Castration Resistant Prostate Cancer Treatment Product
    Table 104. Abbott Laboratories Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 105. Abbott Laboratories Recent Developments
    Table 106. Bayer Healthcare Pharmaceuticals Company Details
    Table 107. Bayer Healthcare Pharmaceuticals Business Overview
    Table 108. Bayer Healthcare Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product
    Table 109. Bayer Healthcare Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 110. Bayer Healthcare Pharmaceuticals Recent Developments
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Castration Resistant Prostate Cancer Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Hormonal Therapy Features
    Figure 3. Adding An Anti-Androgen Features
    Figure 4. Stopping An Anti-Androgen Features
    Figure 5. Estrogens Features
    Figure 6. Chemotherapy Features
    Figure 7. Radiation Therapy Features
    Figure 8. Others Features
    Figure 9. Global Castration Resistant Prostate Cancer Treatment Market Share by Application: 2021 VS 2028
    Figure 10. Hospital Case Studies
    Figure 11. Ambulatory Surgical Centers Case Studies
    Figure 12. Castration Resistant Prostate Cancer Treatment Report Years Considered
    Figure 13. Global Castration Resistant Prostate Cancer Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Castration Resistant Prostate Cancer Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Castration Resistant Prostate Cancer Treatment Market Share by Region: 2021 VS 2028
    Figure 16. Global Castration Resistant Prostate Cancer Treatment Market Share by Players in 2021
    Figure 17. Global Top Castration Resistant Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Castration Resistant Prostate Cancer Treatment as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Castration Resistant Prostate Cancer Treatment Revenue in 2021
    Figure 19. North America Castration Resistant Prostate Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 20. North America Castration Resistant Prostate Cancer Treatment Market Size Market Share by Type (2017-2028)
    Figure 21. North America Castration Resistant Prostate Cancer Treatment Market Size Market Share by Application (2017-2028)
    Figure 22. North America Castration Resistant Prostate Cancer Treatment Market Size Share by Country (2017-2028)
    Figure 23. United States Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Canada Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe Castration Resistant Prostate Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 26. Europe Castration Resistant Prostate Cancer Treatment Market Size Market Share by Type (2017-2028)
    Figure 27. Europe Castration Resistant Prostate Cancer Treatment Market Size Market Share by Application (2017-2028)
    Figure 28. Europe Castration Resistant Prostate Cancer Treatment Market Size Share by Country (2017-2028)
    Figure 29. Germany Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. France Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. U.K. Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Italy Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Russia Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Nordic Countries Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 36. Asia Pacific Castration Resistant Prostate Cancer Treatment Market Size Market Share by Type (2017-2028)
    Figure 37. Asia Pacific Castration Resistant Prostate Cancer Treatment Market Size Market Share by Application (2017-2028)
    Figure 38. Asia Pacific Castration Resistant Prostate Cancer Treatment Market Size Share by Region (2017-2028)
    Figure 39. China Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Japan Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. South Korea Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Southeast Asia Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. India Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Australia Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 45. Latin America Castration Resistant Prostate Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 46. Latin America Castration Resistant Prostate Cancer Treatment Market Size Market Share by Type (2017-2028)
    Figure 47. Latin America Castration Resistant Prostate Cancer Treatment Market Size Market Share by Application (2017-2028)
    Figure 48. Latin America Castration Resistant Prostate Cancer Treatment Market Size Share by Country (2017-2028)
    Figure 49. Mexico Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Brazil Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 52. Middle East and Africa Castration Resistant Prostate Cancer Treatment Market Size Market Share by Type (2017-2028)
    Figure 53. Middle East and Africa Castration Resistant Prostate Cancer Treatment Market Size Market Share by Application (2017-2028)
    Figure 54. Middle East and Africa Castration Resistant Prostate Cancer Treatment Market Size Share by Country (2017-2028)
    Figure 55. Turkey Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Saudi Arabia Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. UAE Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. Active Biotech Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
    Figure 59. Diagnocure Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
    Figure 60. Glaxosmithkline Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
    Figure 61. Northwest Biotherapeutics Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
    Figure 62. Millennium Pharmaceuticals Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
    Figure 63. Hologic Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
    Figure 64. Spectrum Pharmaceuticals Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
    Figure 65. Abbott Laboratories Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
    Figure 66. Bayer Healthcare Pharmaceuticals Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2017-2022)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Active Biotech
Diagnocure
Glaxosmithkline
Northwest Biotherapeutics
Millennium Pharmaceuticals
Hologic
Spectrum Pharmaceuticals
Abbott Laboratories
Bayer Healthcare Pharmaceuticals
Frequently Asked Questions
Castration Resistant Prostate Cancer Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Castration Resistant Prostate Cancer Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Castration Resistant Prostate Cancer Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Cat Allergy

Cat Allergy market is segmented by players, region (country), by Type and by Application. Players ... Read More

Cathode Materials

Cathode Materials market is segmented by Type and by Application. Players, stakeholders, and othe ... Read More